Home Tags Iksuda Therapeutics

Tag: Iksuda Therapeutics

Iksuda Therapeutics Closes Financing Round with Mirae Asset Capital, Celltrion and...

A developer of a new generation of antibody-drug conjugates, Iksuda Therapeutics, has completed a US $47 million (UK £34 million) financing round.  The financing...

LegoChem Biosciences and Iksuda Sign Multi-Target Research Collaboration and License Agreement

In a statement, South Korean LegoChen Biosciences and UK's Iksuda Therapeutics confirmed that the companies have entered into a multi-target research collaboration and license...
Featured Image: Scientist in Biomedical Laboratory. Courtesy 2019 Fotolia. used with permission.

Femtogenix Signs License Agreement with Iksuda Therapeutics

Iksuda Therapeutics, formerly known as Glythera, confirmed that it has signed a licensing agreement with Femtogenix. The agreement gives Iksuda access to Femtogenix’s therapeutic,...

X